Celanese Corporation (CE) - Total Liabilities

Latest as of March 2026: $17.25 Billion USD

Based on the latest financial reports, Celanese Corporation (CE) has total liabilities worth $17.25 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Celanese Corporation (CE) net asset momentum to track the company's year-over-year net asset growth rate.

Celanese Corporation - Total Liabilities Trend (2001–2025)

This chart illustrates how Celanese Corporation's total liabilities have evolved over time, based on quarterly financial data. See Celanese Corporation (CE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Celanese Corporation Competitors by Total Liabilities

The table below lists competitors of Celanese Corporation ranked by their total liabilities.

Company Country Total Liabilities
Companhia de Saneamento de Minas Gerais
SA:CSMG3
Brazil R$9.16 Billion
Minera Frisco S.A.B. de C.V
MX:MFRISCOA-1
Mexico MX$19.87 Billion
Anhui Yingliu
SHG:603308
China CN¥9.16 Billion
Turkcell Iletisim Hizmetleri AS
NYSE:TKC
USA $248.39 Billion
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
Germany €11.06 Billion
Xinfengming Group Co Ltd
SHG:603225
China CN¥46.00 Billion
Allfunds Group Ltd
AS:ALLFG
Netherlands €4.07 Billion
Banpu Public Company Limited
BK:BANPU
Thailand ฿9.39 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Celanese Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Celanese Corporation worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.25 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.79 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Celanese Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Celanese Corporation (2001–2025)

The table below shows the annual total liabilities of Celanese Corporation from 2001 to 2025.

Year Total Liabilities Change
2025-12-31 $17.22 Billion -0.14%
2024-12-31 $17.25 Billion -9.44%
2023-12-31 $19.05 Billion -5.56%
2022-12-31 $20.17 Billion +171.13%
2021-12-31 $7.44 Billion +6.05%
2020-12-31 $7.01 Billion +6.63%
2019-12-31 $6.58 Billion +10.85%
2018-12-31 $5.93 Billion -4.89%
2017-12-31 $6.24 Billion +16.92%
2016-12-31 $5.34 Billion -7.31%
2015-12-31 $5.76 Billion +0.30%
2014-12-31 $5.74 Billion -9.16%
2013-12-31 $6.32 Billion -14.93%
2012-12-31 $7.43 Billion +3.50%
2011-12-31 $7.18 Billion -2.45%
2010-12-31 $7.36 Billion -5.99%
2009-12-31 $7.83 Billion +12.09%
2008-12-31 $6.98 Billion -0.13%
2007-12-31 $6.99 Billion -0.61%
2006-12-31 $7.03 Billion -1.57%
2005-12-31 $7.15 Billion +2.03%
2004-12-31 $7.00 Billion +66.21%
2003-12-31 $4.21 Billion -2.48%
2002-12-31 $4.32 Billion +1.01%
2001-12-31 $4.28 Billion --

About Celanese Corporation

NYSE:CE USA Chemicals
Market Cap
$4.73 Billion
Market Cap Rank
#3706 Global
#1297 in USA
Share Price
$43.14
Change (1 day)
-4.64%
52-Week Range
$35.53 - $69.24
All Time High
$169.28
About

Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more